期刊文献+

消化系统神经内分泌肿瘤诊治难点和热点 被引量:1

Focused dilemmas in the diagnosis and treatment of digestive system neuroendocrine neoplasms
原文传递
导出
摘要 神经内分泌肿瘤(NENs)起源于全身弥漫分布的神经内分泌细胞,临床上易误诊、漏诊,给临床诊治带来巨大困难,严重影响其预后。本文将从NENs的实验室及病理检查、内镜诊治、生长抑素、免疫检查点抑制剂、肽受体放射性核素治疗等方面介绍NENs诊治的难点和热点,旨在为NENs早诊早治、中晚期高级别NENs的规范化诊治提供思路,为临床多学科专家对NENs综合处理提供更多策略。 Neuroendocrine neoplasms(NENs)originate from neuroendocrine cells diffusely distributed throughout the body.NENs are liable to be misdiagnosed and missed clinically,which brings great difficulties to clinical diagnosis and treatment,and seriously affects their prognosis.This article will introduce the difficulties and hot spots in the diagnosis and treatment of NENs from the aspects of laboratory and pathological examinations,anatomical and functional imaging examinations,including endoscopy,peptide receptor radionuclide therapy,somatostatin analogue and immune checkpoint inhibitor therapy.It aims to provide more ideas for the early diagnosis and early treatment of NENs,standardized diagnosis and treatment of high-grade NENs in the middle and late stages,and to provide more strategies for clinical multidisciplinary experts towards the management of focused dilemmas in NENs.
作者 汤琪云 王峰 刘云 Tang Qiyun;Wang Feng;Liu Yun(Department of Geriatric Gastroenterology,First Affiliated Hospital of Nanjing Medical University,Nanjing 210029,China;Department of Nuclear Medicine,First Affiliated Hospital of Nanjing Medical University,Nanjing 210029,China;Department of Geriatrics,First Affiliated Hospital of Nanjing Medical University,Nanjing 210029,China)
出处 《中华医学杂志》 CAS CSCD 北大核心 2022年第14期977-981,共5页 National Medical Journal of China
基金 江苏省医学重点人才项目(ZDRCA2016008)。
关键词 神经内分泌瘤 内镜 生长抑素 免疫检查点抑制剂 肽受体放射性核素治疗 Neuroendocrine tumors Endoscopy Somatostatin analogue Immune checkpoint inhibitors Peptide receptor radionuclide therapy
  • 相关文献

参考文献8

二级参考文献96

  • 1蒋卫君,刘彤华,陈杰,高洁,武莎斐,陈原稼.胰岛素瘤频发MEN-1抑癌基因及22q的杂合缺失及其意义[J].中华医学杂志,2004,84(20):1705-1709. 被引量:9
  • 2Niederle MB, Hackl M, Kaserer K, Niederle B. Gastroenteropancreaticneuroendocrine tumours: the current incidence andstaging based on the WHO and European Neuroendocrine Tumour Society classification: an analysis based on prospectively collectedparameters. Endocr Relat Cancer 2010; 17: 909-918 [PMID:20702725 DOI: 10.1677/ERC-10-0152].
  • 3Fraenkel M, Kim M, Faggiano A, de Herder WW, Valk GD;Knowledge NETwork. Incidence of gastroenteropancreaticneuroendocrine tumours: a systematic review of the literature.Endocr Relat Cancer 2014; 21: R153-R163 [PMID: 24322304DOI: 10.1530/ERC-13-0125].
  • 4Kidd M, Gustafsson B, Modlin IM. Gastric carcinoids(neuroendocrine neoplasms). Gastroenterol Clin North Am 2013;42: 381-397 [PMID: 23639647 DOI: 10.1016/j.gtc.2013.01.009].
  • 5Lawrence B, Gustafsson BI, Chan A, Svejda B, Kidd M, ModlinIM. The epidemiology of gastroenteropancreatic neuroendocrinetumors. Endocrinol Metab Clin North Am 2011; 40: 1-18, vii[PMID: 21349409 DOI: 10.1016/j.ecl.2010.12.005].
  • 6Yao JC, Hassan M, Phan A, Dagohoy C, Leary C, Mares JE,Abdalla EK, Fleming JB, Vauthey JN, Rashid A, Evans DB. Onehundred years after "carcinoid": epidemiology of and prognosticfactors for neuroendocrine tumors in 35,825 cases in the UnitedStates. J Clin Oncol 2008; 26: 3063-3072 [PMID: 18565894 DOI:10.1200/JCO.2007.15.4377].
  • 7Ellis L, Shale MJ, Coleman MP. Carcinoid tumors of thegastrointestinal tract: trends in incidence in England since 1971.Am J Gastroenterol 2010; 105: 2563-2569 [PMID: 20823835 DOI:10.1038/ajg.2010.341].
  • 8Modlin IM, Lye KD, Kidd M. A 50-year analysis of 562 gastriccarcinoids: small tumor or larger problem- Am J Gastroenterol2004; 99: 23-32 [PMID: 14687136].
  • 9Delle Fave G, Kwekkeboom DJ, Van Cutsem E, Rindi G,Kos-Kudla B, Knigge U, Sasano H, Tomassetti P, Salazar R,Ruszniewski P; Barcelona Consensus Conference participants.ENETS Consensus Guidelines for the management of patients withgastroduodenal neoplasms. Neuroendocrinology 2012; 95: 74-87[PMID: 22262004 DOI: 10.1159/000335595].
  • 10Vannella L, Sbrozzi-Vanni A, Lahner E, Bordi C, Pilozzi E,Corleto VD, Osborn JF, Delle Fave G, Annibale B. Development oftype I gastric carcinoid in patients with chronic atrophic gastritis.Aliment Pharmacol Ther 2011; 33: 1361-1369 [PMID: 21492197DOI: 10.1111/j.1365-2036.2011.04659.x].

共引文献136

同被引文献5

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部